Pegylated liposomal doxorubicin (Doxil)

liposomal doxorubicin · Janssen Pharmaceuticals (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated liposomal doxorubicin (Doxil), covering 2015-09-29 to 2015-09-29. Get the full timeline:

Most recent: Clinical Trial Update: AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR [Phase 1]

See pricing